• Skip to main content
  • Skip to footer
cnb1439_3rs-project_nav-ad_v2
  • About us
  • News
  • Events
  • Careers
cn-bio-organ-on-a-chip-logo
  • Products
    • PhysioMimix® Core Microphysiological System
    • Consumables
      • PhysioMimix® Multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Gut/Liver-on-a-chip
    • Lung-on-a-chip
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Technology
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers in Biotech
  • Contact us

Explore our solutions


PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.

PhysioMimix Core

cnb1476_physiomimix-core_mark_mocks_system_v2
Learn more

Consumables

Multi-chip plates
3D validated cells
NASH-in-a-box
Bioavailability assay kit: Human 18
DILI assay kit: Human 24
Learn more

Models

Single-organ models
- Liver-on-a-chip model
- Lung-on-a-chip model
Multi-organ models
- Gut/Liver-on-a-chip models

Support packages

PhysioMimix® support packages

Discover the applications


Investigate the validated core application areas that our PhysioMimix® products and services support

Learn more

Disease modeling

Metabolic dysfunction-associated steatohepatitis
Hepatitis B
Pulmonary infection
Learn more

Safety toxicology

Drug-induced liver injury
Immune-mediated liver injury
Learn more

ADME

Drug absorption
Drug metabolism
Drug bioavailability
Oligonucleotide delivery
Learn more

Studies as a service


Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

Learn more
icon-nash-1-150x150.png MASLD/MASH
icon-dili-tox-150x150.png Drug-induced liver injury
icon-adme-150x150.png ADME

Transform drug discovery with predictive human organ models


We are an Organ-on-a-chip company that enables you to generate human-specific efficacy, ADME and safety data with pioneering PhysioMimix® solutions

cnb1513 physiomimix core mark mock hero v2 | organ-on-a-chip company

Introducing
PhysioMimix® Core

This launch combines our single-organ, multi-organ, and high-throughput configurations within one scalable platform.

Learn more

Areas to explore


New approach methodologies (NAMs), including Organ-on-a-chip (OOC), represent the key to faster, more accurate drug discovery. Explore how to harness the power of PhysioMimix® Core in your lab, or via our contract research services.

Products icon

Products

Learn more about PhysioMimix® Core and why it’s helping drive OOC adoption

Explore PhysioMimix Core

Applications icon

Applications

Explore our highly characterized and validated PhysioMimix® Core applications

PhysioMimix application areas

Services icon

Services

Access the power of PhysioMimix® through our contract research service

Our OOC services

icon cog | organ-on-a-chip company

Technology

Discover why the technology that powers PhysioMimix is like no other

Explore PhysioMimix tech

PhysioMimix® Core: Mimics human physiology like no other


PhysioMimix Core models human-specific biology, which animals lack. Unlock effects that manifest only in human tissue to improve the accuracy and efficiency of drug discovery

  • Human-relevant, translatable data
  • Single-, multi-organ and higher throughput capabilities
  • Flexible and customizable
  • Easy to adopt, simple to use
  • Broad drug modality compatibility, including monoclonal antibodies, oligonucleotides and traditional small molecules
Image of the PhysioMimix Core System

10+

years of OOC industry experience and know-how

70%

of our employees are scientists and engineers

16/20

top pharmaceutical companies use PhysioMimix®

Using the PhysioMimix® System is really straightforward; with a little practice, any tissue culture scientist can master the skills needed for Organ-on-a-chip (OOC) assays

Dr. Déborah Lenart

Research Scientist, Charles River Laboratories

Explore PhysioMimix

What’s new?

Resources

cnb1473 primary human gut liver microphysiological system pub resource tmb v1 | organ-on-a-chip company

New Scientific publication

A primary human Gut/Liver microphysiological system to estimate human oral bioavailability…

Learn more

Industry news

3D cells blog

3Rs project with FDA

CN Bio to participate in 3Rs Collaborative-lead project with FDA to build confidence in Liver MPS for DILI…

Learn more

Partnerships

Inipharm | organ-on-a-chip company

PhysioMimix data for Inipharm

PhysioMimix® Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment…

Learn more

Press release

cnb1520 physioMimix core pr tmb v1 | organ-on-a-chip company

PhysioMimix Core launch

CN Bio launches all-in-one microphysiological system, PhysioMimix® Core, for future-proofed Organ-on-a-chip research

Learn more

Speak to our experts

Request a meeting with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Regulatory | Accessibility
Website terms | Terms of sale

Product Recycling

©2025 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • CN Bio launches all-in-one Organ-on-a-chip system, PhysioMimix® Core October 14, 2025
  • Regulatory Shifts and Validation: Key Insights from The World Congress on Alternatives and Animal Use in the Life Sciences Conference (WC13) September 30, 2025
  • CN Bio adds computational modelling capabilities to ADME services for enhanced bioavailability profiling September 1, 2025
Cyber Essentials Logo